Injectable drug delivery is a method of drug administration inside a body with the help of needle through various route such as intravenous, intramuscular, or direct injection. The drug used in injectable drug delivary is usually in powder or crystal form. Injected drugs are majorly used in health care for diagnosis, treatment, and prevention of various diseases. Injectable drug dileveray is preffered over oral dosage form in emergency conditions due to less time taken by the drug for absorbtion and metabolization. Accoding to the World Health Organizaion (WHO), an ideal injection should not pose any risk or harm to recipient, and also does not produce any waste dangerous to the community. Traditionally, injectables were majorly designed for delivery of human growth harmones, and insulin. However, technological advancements expanded the application of injectables for the deliveary of various drug classes such as serotonin antagonists, anticholinergic, reproductive hormones, dopamine agonists, parathyroid hormones, sympathomimetic, hematopoietic, and immune modulators. 

Request Full TOC: http://www.persistencemarketresearch.com/toc/5741

European injectable drug delivery market could be majorly segmented by product type, usage, route of administration, and region. Based on product type European injectable drug delivery market could be further segmented into formulations and devices. Formulations for injectables can be further sub divided into conventional drug delivery formulations, new drug delivery formulations, and long acting formulations. Devices segment can be classified into conventional injectable devices, self injection devices, and others (microneedles, nanoneedles, and blunt needle injection). Based on the usage, drug injectable drug delivery market could be categorized into curative care, immunization, and other. Depending on route of administration, the European drug injectable market could be segmented into intravenous, intraperitoneal, subcutaneous, and intramuscular. Geographically, the European drug injectable market segmented into Germany, France, Spain, U.K., Italy, and rest of Europe. At present, on the basis of product type formulation types accounted for the largest share of the market and is expected to dominate the market during the forecast period.  increasing prevalence of chronic diseases, growth of biologics market, technological advancement, and decrease in side effects offered by formulations are the major factors anticipated to grow the formulations market. In devices segment, industry is witnessing shift towards self injectable devices and is estimated to be the fastest growing segment. Self injectable devices include pen injector and auto injector are gaining importance as they offer fewer side effects. Geographically, Germany dominated the European drug injectable market followed by France in 2014 due to patient compliance, increasing demand for self injectable devices, advancement in technology, and presence of key players in Germany.

Buy Full Report: http://www.persistencemarketresearch.com/market-research/european-injectable-drug-delivery-market.asp

European drug injectable market growth is being fuelled by favorable reimbursement policies, rising incidence of cancer, HIV, and diabetes, and increasing patient compliance with injectables. Additionally, entry of newer injectable drugs in the market during the forecast period is expected to propel the market growth. For instance, in March 2015, Novo Nordisk received a marketing approval from the European Commision for Saxenda, a drug intended to treat obesity. According to the WHO, obesity affected 39% of adults in 2014. Thus, the market is expected to grow based on above mentioned factors. However, safety concerns, pain assoaciated with injections, risk of blood born infections, and availability of alternative delivery methods such as oral and transdermal are key reasons anticipated to restraint the growth of the European drug injectable market. According to European Centre for Disease Prevention and Control (ECDC), people who inject the drugs (PWID) are at increased risk of HIV infection in Europe.  For instance, in 2012 prevalence of HIV was  observed 5% or more among PWID in 19 countries of Europe such as Spain, France, Swizerland, and Italy. Hence, the safety is a major issue related to injectable drug which might restraint the market growth. 

Major players operating in the European drug delivery market includes Becton, Dickinson and Company, Baxter International, Pfizer, Inc., Gerresheimer AG, Schott AG, Sandoz, Teva Pharmaceutical Industries Limited, Eli Lilly and Company, and Alkermes.

Key points covered in the report
1) Report segments the market on the basis of types, application, products, technology, etc (as applicable)
2) The report covers geographic segmentation
   North America
   Europe
   Asia
   RoW
3) The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020
4) The report provides company profiles of some of the leading companies operating in the market
5) The report also provides porters five forces analysis of the market.
        
About Us
Persistence Market Research (PMR) is a  full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values. 

Contact
Addie Thomas
305 Broadway
7th Floor, New York City, 
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com